Effects of an oral vasopressin receptor antagonist (OPC-31260) in a dog with syndrome of inappropriate secretion of antidiuretic hormone

Australian Veterinary Journal

Volumn 78, Issue 12, 2000, Pages 825-830

  Fleeman, L M ^a,b   Irwin, P J ^a   Phillips, P A ^a   West, J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Antidiuresis; Antidiuretic hormone; Aquaresis; Dog; OPC 31260; Osmolality; Plasma renin activity; Sodium; Syndrome of inappropriate secretion of antidiuretic hormone; Vasopressin

Indexed keywords

CANIS FAMILIARIS;

BENZAZEPINE DERIVATIVE; MOZAVAPTAN; SODIUM; VASOPRESSIN RECEPTOR;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CASE REPORT; DOG; DOG DISEASE; DRUG ANTAGONISM; MALE; ORAL DRUG ADMINISTRATION; SCHWARTZ BARTTER SYNDROME; URINE;

ADMINISTRATION, ORAL; ANIMALS; BENZAZEPINES; DOG DISEASES; DOGS; INAPPROPRIATE ADH SYNDROME; MALE; RECEPTORS, VASOPRESSIN; SODIUM;

EID: 0034572628     PISSN: 00050423     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-0813.2000.tb10497.x     Document Type: Article

References (28)

1. Rijnberk A, Biewenga WJ, Mol JA. Inappropriate vasopressin secretion in two dogs. Acta Endocrinol (Copenh) 1988;117:59-64.
2. Moses AM, Streeten DH. Disorders of the neurohypophysis. In: Fauci A S, Braunwald E, Isselbacher K J et al, editors. Harrisons Principles of Internal Medicine. 14th edn. McGraw-Hill, New York, 1998: 2003-2012.
3. Sorenson JB, Anderson MK, Hansen HH. Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease. J Vet Intern Med 1995;238:97-110.
4. Breitschwerdt EB, Root CR. Inappropriate secretion of antidiuretic hormone in a dog. J Am Vet Med Assoc 1979;175:181-186.
5. Biewenga WJ, Rijnberk A, Mol JA. Inappropriate vasopressin secretion in dogs. Tijdschr Diergeneeskd 1988;113 Suppl 1:104-105.
6. Houston DM, Allen DG, Kruth SA et al. Syndrome of inappropriate antidiuretic hormone secretion in a dog. Can Vet J 1989;30:423-425.
7. Oosterhout ICAM, Rijnberk A, Mol JA. Effect of the aquaretic vasopressin antagonists d(CH2)5[D-Tyr(Et)2-Val4]AVP and d(CH2)5[D-Phe2-Phe4]AVP on urine production in healthy dogs. Horm Metab Res 1992;24:244-245.
8. Naitoh M, Suzuki H, Murakami M et al. Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs. Am J Physiol 1994;267(6 Pt 2):H2245-H2254.
9. Brooks DP, Valente M, Petrone G et al. Comparison of the water diuretic activity of kappa receptor agonists and a vasopressin receptor antagonist in dogs. J Pharmacol Exp Ther 1997;280:1176-1183.
10. Biewenga WJ, van den Brom WE, Mol JA. Vasopressin in polyuric syndromes in the dog. Front Horm Res 1987;17:139-148.
11. Meinders AE. Current concept of the role of antidiuretic hormone in osmoregulation and volume regulation in man. Neth J Med 1985;28:401-407.
12. Pullan PT, Johnston CI, Anderson WP, Korner PI. The role of vasopressin in blood pressure control and in experimental hypertension. Clin Sci Mol Med 1978;4Suppl:251S-254S.
13. Johnston CI, Mendelsohn F, Casley D. Evaluation of renin and angiotensin assays and their clinical application. Med J Aust 1971;1:126-128.
14. Burrell LM, Palmer J, Charlton JA et al. A new radio-immunoassay for human alpha atrial natriuretic peptide and its physiological validation. J Immunoass 1990;11:159-175.
15. Tsunoda K, Hodsman GP, Sumithran E, Johnston CI. Atrial natriuretic peptide in chronic heart failure in the rat: a correlation with ventricular dysfunction. Circ Res 1986;59:256-261.
16. Bartter FC, Schwartz WB. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 1967;42:790-806.
17. Haycock GB. The syndrome of inappropriate secretion of antidiuretic hormone. Pediatr Nephrol 1995;9:375-381.
18. Thibonnier M. Vasopressin and blood pressure. Kidney Int 1988;34 Suppl 25:52-56.
19. 2 receptor antagonist. Br J Clin Pharmacol 1992;105:787-791.
20. Ishikawa S, Okada K, Saito T. Effects of new non-peptide arginine vasopressin (AVP) antagonists OPC-31260 and OPC-21268 on cellular action of AVP in cultured rat renal papillary collecting tubule cells. In: Proceedings of the 25th Annual Meeting of the American Society of Nephrology, 1992, Baltimore. American Society of Nephrology, 1992; 794.
21. 2 receptors in conscious dogs. Am J Physiol 1993;265:R934-R942.
22. Fujisawa G, Ishikawa S, Tsuboi Y et al. Therapeutic efficacy of non-peptide ADH antagonist OPC-31260 in SIADH rats. Kidney Int 1993;44:19-23.
23. Saito T, Ishikawa S, Abe K et al. Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Clin Endocrinol Metab 1997;82:1054-1057.
24. Kamoi K. Syndrome of inappropriate antidiuresis without involving inappropriate secretion of vasopressin in an elderly woman: Effect of intravenous administration of the nonpeptide vasopressin V2 receptor antagonist OPC-31260. Nephron 1994;76:111-115.
25. O'Brien DP, Kroll RA, Johnson GC et al. Myelinolysis after correction of hyponatremia in two dogs. J Vet Intern Med 1994;8:40-48.
26. Williams GH, Dluhy RG. Diseases of the adrenal cortex. In: Fauci A S, Braunwald E, Isselbacher K J et al, editors. Harrisons Principles of Internal Medicine. 14th edn. McGraw-Hill, New York, 1998: 2035-2057.
27. Vollmar AM, Montag C, Preusser U et al. Atrial natriuretic peptide and plasma volume of dogs suffering from heart failure or dehydration. J Vet Med 1994;41:548-557.
28. Zerbe R, Stropes L, Robertson G. Vasopressin function in the syndrome of inappropriate antidiuresis. Annu Rev Med 1980;31:315-327.